Source: Health Products Regulatory Authority (IE) Revision Year: 2019 Publisher: Bayer Limited, The Atrium, Blackthorn Road, Dublin 18, Ireland
Urografin 30% w/v Solution for infusion.
| Pharmaceutical Form |
|---|
|
Solution for infusion. A clear, colourless to faintly yellow, odourless, sterile aqueous solution. |
1 ml of Urografin 30% for infusion contains 0.04 g sodium amidotrizoate and 0.26 g meglumine amidotrizoate (sodium diatrizoate and meglumine diatrizoate) in aqueous solution, containing the equivalent of 146 mg of Iodine in combined form per ml.
Excipients: Contains 1.45mg (0.063mmol) sodium per ml (Each 250ml bottle contains 362.5mg sodium).
For a full list of excipients, see section 6.1.
| Active Ingredient | Description | |
|---|---|---|
| Diatrizoic acid |
|
| List of Excipients |
|---|
|
Sodium calcium edetate |
Bottle: colourless glass type II.
Stopper: stopper type I chlorobutyl-elastomer.
Presentation: Bottles of 250 ml.
Bayer Limited, The Atrium, Blackthorn Road, Dublin 18, Ireland
PA1410/012/001
Date of first authorization: 01 April 1988
Date of last renewal: 01 April 2008
| Drug | Countries | |
|---|---|---|
| UROGRAFIN | Estonia, Spain, Ireland, Japan, Lithuania, New Zealand |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.
